NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

OSRH

OSR Holdings Inc

Apr 29 • 10:33AM ET

1.41

Dollar change +0.02
Percentage change 1.58	%

Healthcare • Biotechnology • USA • NASD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.96	Insider Own	-	Shs Outstand	2.32M	Perf Week	4.99%
Market Cap	27.12M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-41.38%
Income	-2.41M	PEG	-	EPS next Q	-	Inst Own	0.35%	Short Float	-	Perf Quarter	-87.93%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	2.55%	Short Ratio	0.04	Perf Half Y	-87.01%
Book/sh	-2.80	P/B	-	EPS next Y	-	ROA	-12.39%	Short Interest	0.16M	Perf Year	-86.41%
Cash/sh	0.00	P/C	387.46	EPS next 5Y	-	ROE	-18.52%	52W Range	1.25 - 13.40	Perf YTD	-87.80%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-265.93%	ROI	-	52W High	-89.50%	Beta	1.57
Dividend TTM	-	Quick Ratio	0.07	Sales past 5Y	0.00%	Gross Margin	-	52W Low	12.55%	ATR (14)	0.34
Dividend Ex-Date	-	Current Ratio	0.07	EPS Y/Y TTM	-2583.76%	Oper. Margin	-	RSI (14)	41.21	Volatility	5.65% 19.36%
Employees	5	Debt/Eq	-	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	-5597.39%	Payout	-	Rel Volume	0.03	Prev Close	1.38
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	4.28M	Price	1.41
SMA20	-7.39%	SMA50	-33.55%	SMA200	-83.68%	Trades		Volume	27,030	Change	1.58%

Apr-09-25 07:54AM	Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology (PR Newswire)
Apr-03-25 07:30AM	OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies (PR Newswire) +68.03%
Mar-26-25 07:16AM	Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma (PR Newswire) +136.87%
Mar-25-25 07:00AM	OSR Holdings Appoints Dr. Constance Hfer as Chief Scientific Officer (PR Newswire) -7.51%

OSR Holdings, Inc. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on February 25, 2020 and is headquartered in Bellevue, WA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OSRH

OSR Holdings Inc

Upgrade your FINVIZ experience